On the stock market since 2024, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
A loss of $134.0M against $0 in annual sales.
On our five-subject report card, HLXB sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: HLXB is a high-risk stock — not yet profitable, and its future rides on its product catching on.